Page last updated: 2024-08-26

nicotine and l 663536

nicotine has been researched along with l 663536 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, C; Fadda, P; Fratta, W; Goldberg, SR; Justinova, Z; Le Foll, B; Lecca, S; Luchicchi, A; Mascia, P; Panlilio, LV; Piomelli, D; Pistis, M; Redhi, GH; Scherma, M; Tanda, G; Yasar, S1
Adair, J; Aliczki, M; Barnes, C; Goldberg, SR; Haller, J; Heishman, SJ; Justinova, Z; Lecca, S; Luchicchi, A; Mascia, P; Panlilio, LV; Pistis, M; Redhi, GH; Yasar, S1

Other Studies

2 other study(ies) available for nicotine and l 663536

ArticleYear
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.
    Biological psychiatry, 2011, Apr-01, Volume: 69, Issue:7

    Topics: Action Potentials; Animals; Behavior, Animal; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Indoles; Male; Microdialysis; Neurons; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Oligosaccharides; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Saimiri; Self Administration; Ventral Tegmental Area

2011
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:8

    Topics: Action Potentials; Animals; Clofibrate; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Hypolipidemic Agents; Indoles; Male; Neurons; Nicotine; Nucleus Accumbens; PPAR alpha; Rats; Rats, Sprague-Dawley; Reward; Saimiri; Secondary Prevention; Self Administration; Tobacco Use Disorder; Ventral Tegmental Area

2012